Skip to content
OpenCapital
Get started

Eikon Therapeutics, Inc. EIKN Q4 2025 Annual earnings

Reported March 30, 2026

Diluted EPS-$27.00Miss by $23.44
EPS estimate-$3.56

Next report

Aug 10, 2026 (in a month)
EPS estimate-$1.61

Financials

Q4 2025

Balance sheet

See full
Cash & equivalents$104.9M—
Total debt$257.3M—
Total equity-$879.0M-53.7%
Total assets$594.7M—

Versus estimates

Diluted EPS

Q4 2025-$27.00Miss by $23.44

Ask the moment Eikon Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Eikon Therapeutics, Inc. report Q4 2025 earnings?
Eikon Therapeutics, Inc. (EIKN) reported Q4 2025 earnings on March 30, 2026.
What were Eikon Therapeutics, Inc. 's Q4 2025 revenue and EPS?
Eikon Therapeutics, Inc. reported diluted EPS of $-27.00 for Q4 2025.
Did Eikon Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-3.56 by $23.44.
Where can I find Eikon Therapeutics, Inc. 's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-130449) and the 10-K periodic report (0001193125-26-130395) directly on SEC EDGAR. The filing index links above go to sec.gov.